Team Overall

04/07/2026

Blast off..

04/07/2026

I guess we are COOL again..
Enjoy the day, Peeps!!

04/06/2026

https://thema*****naherald.com/2026/03/trump-cannabis-descheduling/

President Trump is planning to sign an executive order this summer creating a federal commission to study the descheduling of ma*****na, according to two sources who spoke with The Ma*****na Herald. The move is expected to be made ahead of the November midterms. One of the sources is a longtime seni...

04/06/2026

👁️👁️👁️👁️👁️👁️

04/04/2026

04/04/2026

The wishlist…

04/04/2026

Fenbendazole: Is This Veterinary Staple the Missing Link in Metabolic Oncology?

In the world of oncology, the most significant breakthroughs don’t always come from billion-dollar labs. Sometimes, they are sitting on the shelves of veterinary pharmacies. Fenbendazole—a drug used for decades to deworm livestock—has become the subject of fascinating analysis regarding its potential role in the fight against cancer.

Why would an anti-parasitic drug affect a tumor? The answer lies in biology and metabolism.

1. Parasites: The "Stowaways" That Disable Immunity
Modern medicine often downplays the prevalence of human parasitic infections. However, long-term parasitic burdens are more than just a digestive issue.

➡️They cause:

✅Chronic Inflammation: Draining the body’s immune resources.

✅Immunosuppression: Creating the perfect fertile ground for carcinogenesis (cancer development).

✅Encapsulated Lesions: The body often forms cysts, polyps, or "tumors" as a response to persistent parasitic presence.

2. The "Fuel Blockade": How Fenbendazole Hits Cancer

The key to understanding Fenbendazole is glucose metabolism.

Over 95% of cancer cells suffer from a metabolic defect—they are entirely dependent on sugar (glucose) and cannot efficiently derive energy from fats or proteins (The Warburg Effect).

Fenbendazole acts as a "Fuel Blockade":

✅ Microtubule Disruption: It destabilizes the internal "scaffolding" of both parasites and cancer cells.
✅ Glucose Transport Inhibition: It cuts off the energy supply, leading to programmed cell death (apoptosis) in the tumor.
✅ Metabolic Flexibility: Healthy cells are flexible—they can switch to alternative energy sources—making the drug relatively safe for them while lethal to the tumor.

3. Clinical Observations from the U.S.

Reports from physicians in the United States who have observed patients using Fenbendazole (often as a supportive therapy) indicate:

✅Significant reduction in tumor volume and inhibition of further growth.

✅Complete absorption of certain lesions.

✅A marked increase in overall vitality and physical function.

In most cases, the drug was very well tolerated. Only a few experienced a Herxheimer reaction (nausea, headaches)—a temporary effect caused by the rapid release of toxins from dying cancer cells or parasites.

4. The Veterinary Lesson

Experienced veterinarians have long noted that animals undergoing extended deworming protocols sometimes see their tumors vanish spontaneously—even without conventional oncology. This raises a critical question: How many human "cancers" are actually processes initiated or fueled by unrecognized parasitic loads?
Conclusion and Prevention

Completely avoiding parasites is virtually impossible—they are found in organic produce and even high-end seafood. Periodic deworming, a standard practice in the animal kingdom, should be considered a serious element of proactive human health maintenance.

04/04/2026

04/04/2026

Precision Over Purity:

Why the Future of Medical Cannabis is Genetic, Not Industrial

Lafayette , CO — As the cannabis industry faces a wave of corporate restructuring and "wellness-to-medical" pivots, the Cannabinoid Outreach & Opportunity Program (C.O.O.P.) is setting a new benchmark for what patients—specifically seniors and veterans—actually need: Standardized Medication.
While legacy brands are simplifying formulas by removing acidic cannabinoids and terpenes to meet mass-production goals, C.O.O.P. is doubling down on the clinical power of the whole plant. By utilizing advanced tissue culture and precision microdosing, C.O.O.P. is providing the consistent, solventless medicine required for the 2026 CMS Substance Access Initiative.
The Standardization Gap
The difference between "consumer-grade" and "clinical-grade" comes down to how a company defines stability:
• The Corporate Model: Relies on heavy processing and decarboxylation to create a "one-size-fits-all" extract. By minimizing the acidic side and terpenes, these products often lose the nuanced therapeutic benefits of the plant in exchange for industrial repeatability.
• The C.O.O.P. Model: Achieves standardization through Biology. Using Mothership Labs’ tissue culture, C.O.O.P. ensures every plant is a genetic identical. This preserves the critical acidic cannabinoids (CBDA/CBGA) and terpene profiles while delivering the exact dosing precision (e.g., 3 mg) that physicians require.

"True medical integration isn't about fitting a wellness brand into a healthcare system; it’s about building the infrastructure that healthcare demands," says Todd Young, Co-Founder of C.O.O.P. "Our patients don't need a simplified commodity—they need a clean, solventless, and genetically consistent medicine they can trust every single time."

Owned by Patients
Modeled as a non-profit cooperative, C.O.O.P. prioritizes clinical outcomes over shareholder dividends. As a patient-owned utility, every member has a voice in the mission to provide safe, affordable, and standardized cannabinoid therapy.
About C.O.O.P.
The Cannabinoid Outreach & Opportunity Program (C.O.O.P.) is a non-profit, patient-owned cooperative dedicated to community wellness and medical access. Focused on clinical-grade compliance and solventless production, C.O.O.P. provides precision-standardized medicine for seniors, veterans, and medical patients across the U.S.

04/03/2026

Empowering the Future of Wellness:

Introducing the Cannabinoid Outreach & Opportunity Program (C.O.O.P.)
We are proud to officially announce the Cannabinoid Outreach & Opportunity Program (C.O.O.P.), a non-profit initiative dedicated to bridging the gap between advanced botanical science and community empowerment.
As the landscape of wellness evolves, C.O.O.P. stands at the forefront, ensuring that education, operational excellence, and professional opportunity are accessible to all. Our mission is built on three essential pillars:
• Education & Advocacy: Providing transparent, science-based information to foster community trust and informed wellness choices.
• Operational Excellence: Setting the gold standard for facility management, medical-grade formulations, and industry-leading SOPs.
• Opportunity & Inclusion: Creating sustainable pathways for professional growth and leadership within the cannabinoid and wellness sectors.
C.O.O.P. is more than a program; it is a collaborative hub for innovation. From overseeing state-of-the-art laboratory developments to partnering with global wellness leaders, we are committed to shaping a future defined by integrity and standardized excellence.
Join us as we cultivate a community of opportunity.
Connect with C.O.O.P.
• Focus: Medical | Functional | Wellness
• Mission: National Outreach. Creating Opportunities. Community Empowerment.